# OnCo record nct06508658 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06508658/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06508658", "NCT06508658" ;
  schema:name "A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcita"@en ;
  schema:alternateName "EPCORE DLBCL-4"@en ;
  schema:description "A phase 3 trial of Epcoritamab, Rituximab, Lenalidomide in diffuse large b-cell lymphoma, run by Genmab, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06508658/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06508658> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-08-13" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/protac-degrader/>, <https://onco.cc/technologies/t-cell-engager/> ;
  onco:drugs <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/genmab/> .